ALPCO launched a new panel of 13 stool-based gastroenterology assays, which consists of various biomarkers to aid in the investigation of IBD.
Exact Sciences filed a lawsuit against Humana in a Kentucky federal court over the payer’s refusal to reimburse for $800,000 in Cologuard claims.
Physicians Endoscopy formed a new agreement with kiosk company Clearwave to improve the patient registration process.
The combination drug elbasvir/grazoprevir (Zepatier) from Merck received FDA approval. Zepatier is designed to treat hepatitis C genotypes 1 and 4.
Healthmark added the Scope Holder to its GI product line.
Takeda Pharmaceuticals‘ Dexilant SoluTab delayed-release orally disintegrating tablets received FDA approval. The proton pump inhibitor indicated for the treatment of heartburn associated with symptomatic non-erosive gastroesophageal reflux disease, the maintenance of healed erosive esophagitis and relief of heartburn in adults.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.
More articles on gastroenterology:
DuPage Medical Group acquires Midwest Digestive Disease Specialists: 3 things to know
8 must-reads on colonoscopy
5 things to know about office visit costs prior to screening colonoscopy
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
